HER2-POSITIVE BLADDER CANCER

Clinical trials for HER2-POSITIVE BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new HER2-POSITIVE BLADDER CANCER trials appear

Sign up with your email to follow new studies for HER2-POSITIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets Tough-to-Treat HER2 cancers, including brain spread

Disease control Recruiting now

This is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …

Matched conditions: HER2-POSITIVE BLADDER CANCER

Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

HER2-POSITIVE BLADDER CANCER

Get alerted when new HER2-POSITIVE BLADDER CANCER trials appear

New drug trial targets Tough-to-Treat HER2 cancers, including brain spread